City

Baltimore (1)

Seattle (1)

Overall Status

Completed (2)

Phase

phase 2 (2)

Sponsor

Fred Hutchinson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

fludarabine phosphate (2)

allogeneic hematopoietic stem cell transplantation (1)

busulfan (1)

cyclophosphamide (1)

cyclosporine (1)

laboratory biomarker analysis (1)

peripheral blood stem cell transplantation (1)

total-body irradiation (1)

triapine (1)

Study Documents

Intervention Type

drug (2)

procedure (2)

radiation (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

philadelphia chromosome negative chronic myelogenous leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic

Completed

Has Results

Accelerated Phase Chronic Myelogenous Leukemia
+67 more

cyclophosphamide
+6 more

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

May 17, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic

Completed

Has Results

Accelerated Phase Chronic Myelogenous Leukemia
+9 more

fludarabine phosphate
+2 more

Baltimore, Maryland

Johns Hopkins University/Sidney Kimmel Cancer Center

Dec 16, 2014